Matches in SemOpenAlex for { <https://semopenalex.org/work/W3007251745> ?p ?o ?g. }
- W3007251745 endingPage "1499.e2" @default.
- W3007251745 startingPage "1491" @default.
- W3007251745 abstract "Background Recent high-resolution computed tomography studies after transcatheter aortic valve insertion (TAVI) have reported a high prevalence of subclinical valve thrombosis (SCVT), potentially contributing to increased risk of late stroke. We aimed to investigate SCVT in patients after TAVI, with a focus on prevalence, predisposing factors, management, and potential sequelae. Methods A comprehensive literature review of patients with SCVT after TAVI was carried out on all published studies in 3 major electronic databases from their inception until October 2019. Studies with sufficient data were included in a meta-analysis comparing the risk of stroke between patients with SCVT and those with normal valve function, as well as the protective effects of antiplatelet and anticoagulation on preventing SCVT. Results From 3456 patients examined in a comprehensive review, 398 patients (11.5%) demonstrated evidence of SCVT during follow-up. Dual antiplatelet therapy was given in 45.5% of cases, single antiplatelet therapy in 19.8%, and oral anticoagulation in 28.5%. A meta-analysis demonstrated that rates of stroke were more than 3 times greater in patients with SCVT compared with those without (logistic odds, 1.10; 95% confidence interval, 0.63-1.57, P < .0001). Oral anticoagulation was superior to dual antiplatelet therapy or single antiplatelet therapy, preventing the formation of SCVT (logistic odds, –1.05, 95% confidence interval, –1.71 to –0.39, P < .0001). Conclusions Subclinical valve thrombosis is seen in 11.5% of patients after TAVI and is associated with increased risk of stroke. When oral anticoagulation is used postprocedurally, it is more effective than either dual or single-antiplatelet therapy in preventing subclinical valve thrombosis. These findings suggest that further studies are needed to define the optimal antithrombotic regimen to mitigate thrombotic and embolic sequelae after TAVI." @default.
- W3007251745 created "2020-03-06" @default.
- W3007251745 creator A5009121061 @default.
- W3007251745 creator A5011948462 @default.
- W3007251745 creator A5020191906 @default.
- W3007251745 creator A5040608660 @default.
- W3007251745 creator A5049306806 @default.
- W3007251745 creator A5055195885 @default.
- W3007251745 creator A5087169102 @default.
- W3007251745 date "2021-11-01" @default.
- W3007251745 modified "2023-10-13" @default.
- W3007251745 title "Subclinical valve thrombosis in transcatheter aortic valve implantation: A systematic review and meta-analysis" @default.
- W3007251745 cites W1911572690 @default.
- W3007251745 cites W1979996401 @default.
- W3007251745 cites W1994930294 @default.
- W3007251745 cites W1998067192 @default.
- W3007251745 cites W2022311307 @default.
- W3007251745 cites W2030595401 @default.
- W3007251745 cites W2054265385 @default.
- W3007251745 cites W2067905792 @default.
- W3007251745 cites W2085174670 @default.
- W3007251745 cites W2121810036 @default.
- W3007251745 cites W2139815140 @default.
- W3007251745 cites W2140289152 @default.
- W3007251745 cites W2141975603 @default.
- W3007251745 cites W2156222569 @default.
- W3007251745 cites W2161286193 @default.
- W3007251745 cites W2165159075 @default.
- W3007251745 cites W2165258820 @default.
- W3007251745 cites W2167999509 @default.
- W3007251745 cites W2170852352 @default.
- W3007251745 cites W2204587759 @default.
- W3007251745 cites W2254220616 @default.
- W3007251745 cites W2316359512 @default.
- W3007251745 cites W2318441640 @default.
- W3007251745 cites W2322210008 @default.
- W3007251745 cites W2324073140 @default.
- W3007251745 cites W2514702069 @default.
- W3007251745 cites W2524318696 @default.
- W3007251745 cites W2531392384 @default.
- W3007251745 cites W2547336135 @default.
- W3007251745 cites W2562811262 @default.
- W3007251745 cites W2586751944 @default.
- W3007251745 cites W2598430163 @default.
- W3007251745 cites W2601913781 @default.
- W3007251745 cites W2741722288 @default.
- W3007251745 cites W2768017489 @default.
- W3007251745 cites W2781038309 @default.
- W3007251745 cites W2808121323 @default.
- W3007251745 cites W2888351435 @default.
- W3007251745 cites W2900018253 @default.
- W3007251745 cites W2939640252 @default.
- W3007251745 cites W2970082500 @default.
- W3007251745 cites W4250688229 @default.
- W3007251745 cites W43884334 @default.
- W3007251745 doi "https://doi.org/10.1016/j.jtcvs.2020.01.084" @default.
- W3007251745 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32217021" @default.
- W3007251745 hasPublicationYear "2021" @default.
- W3007251745 type Work @default.
- W3007251745 sameAs 3007251745 @default.
- W3007251745 citedByCount "13" @default.
- W3007251745 countsByYear W30072517452020 @default.
- W3007251745 countsByYear W30072517452021 @default.
- W3007251745 countsByYear W30072517452022 @default.
- W3007251745 countsByYear W30072517452023 @default.
- W3007251745 crossrefType "journal-article" @default.
- W3007251745 hasAuthorship W3007251745A5009121061 @default.
- W3007251745 hasAuthorship W3007251745A5011948462 @default.
- W3007251745 hasAuthorship W3007251745A5020191906 @default.
- W3007251745 hasAuthorship W3007251745A5040608660 @default.
- W3007251745 hasAuthorship W3007251745A5049306806 @default.
- W3007251745 hasAuthorship W3007251745A5055195885 @default.
- W3007251745 hasAuthorship W3007251745A5087169102 @default.
- W3007251745 hasConcept C113280763 @default.
- W3007251745 hasConcept C126322002 @default.
- W3007251745 hasConcept C127413603 @default.
- W3007251745 hasConcept C141071460 @default.
- W3007251745 hasConcept C156957248 @default.
- W3007251745 hasConcept C164705383 @default.
- W3007251745 hasConcept C2780645631 @default.
- W3007251745 hasConcept C2780868729 @default.
- W3007251745 hasConcept C44249647 @default.
- W3007251745 hasConcept C71924100 @default.
- W3007251745 hasConcept C78519656 @default.
- W3007251745 hasConcept C95190672 @default.
- W3007251745 hasConceptScore W3007251745C113280763 @default.
- W3007251745 hasConceptScore W3007251745C126322002 @default.
- W3007251745 hasConceptScore W3007251745C127413603 @default.
- W3007251745 hasConceptScore W3007251745C141071460 @default.
- W3007251745 hasConceptScore W3007251745C156957248 @default.
- W3007251745 hasConceptScore W3007251745C164705383 @default.
- W3007251745 hasConceptScore W3007251745C2780645631 @default.
- W3007251745 hasConceptScore W3007251745C2780868729 @default.
- W3007251745 hasConceptScore W3007251745C44249647 @default.
- W3007251745 hasConceptScore W3007251745C71924100 @default.
- W3007251745 hasConceptScore W3007251745C78519656 @default.
- W3007251745 hasConceptScore W3007251745C95190672 @default.
- W3007251745 hasFunder F4320307778 @default.